Evidence map›Paper›PMID 27855182›Full record

ArticlePloS one2016

A Non-Human Primate Model of Severe Pneumococcal Pneumonia.

Luis F Reyes, Marcos I Restrepo, Cecilia A Hinojosa, Nilam J Soni, Anukul T Shenoy, Ryan P Gilley, Norberto Gonzalez-Juarbe, Julio R Noda, Vicki T Winter, Melissa A de la Garza and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Nonhuman Primates in Translational Research.Annual review of animal biosciences · 2022
    Review
  9. Review
  10. Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Observational
  11. Short- and long-term outcomes after incident pneumonia in adults with chronic kidney disease: a time-dependent analysis from the Stockholm CREAtinine Measurement project.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2020
    Article
  12. Pathology Associated WithVeterinary pathology · 2020
    Article
  13. Article
  14. Review
  15. Review
  16. Animal Models ofInternational journal of molecular sciences · 2019
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Luis F ReyesDivision of Pulmonary Diseases & Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Marcos I RestrepoDivision of Pulmonary Diseases & Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Cecilia A HinojosaDivision of Pulmonary Diseases & Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Nilam J SoniDivision of Pulmonary Diseases & Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Anukul T ShenoyDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, AL, United States of America.
Ryan P GilleyDepartment of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Norberto Gonzalez-JuarbeDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, AL, United States of America.
Julio R NodaDivision of Pulmonary Diseases & Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Vicki T WinterDepartment of Pathology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Melissa A de la GarzaTexas Biomedical Research Institute, San Antonio, TX, United States of America.
Robert E ShadeTexas Biomedical Research Institute, San Antonio, TX, United States of America.
Jacqueline J CoalsonDepartment of Pathology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Luis D GiavedoniTexas Biomedical Research Institute, San Antonio, TX, United States of America.
Antonio AnzuetoDivision of Pulmonary Diseases & Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Carlos J OrihuelaDepartment of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
The University of Texas Health Science Center at San Antonio · USTexas Biomedical Research Institute · USUniversity of Alabama at Birmingham · USSouth Texas Veterans Health Care System · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
Mentored Experiences in Research, Instruction and Teaching (MERIT) Program - administrative supplementK12GM088010 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHNEIDER, DAVID ALAN · 2009 to 2024
$9.2M
Cardiac microlesion formation during invasive pneumococcal diseaseR01AI114800 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Carlos J Orihuela, Herve S TETTELIN · 2015 to 2026
$5.1M
Effect of macrolides as immunomodulators in patients with sepsis and pneumoniaK23HL096054 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI RESTREPO, MARCOS I. · 2010 to 2014
$689k
Institute for Integration of Medicine & Science: A Partnership to Improve HealthTL1TR001119 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$640k
NCATS NIH HHS TL1 TR001119NCATS NIH HHS UL1 TR001120NHLBI NIH HHS K23 HL096054NIAID NIH HHS R01 AI114800NIAID NIH HHS T32 AI007051NIGMS NIH HHS K12 GM088010NIH HHS P51 OD011133
6 · The paper itself

Abstract

rationaleStreptococcus pneumoniae is the leading cause of community-acquired pneumonia and infectious death in adults worldwide. A non-human primate model is needed to study the molecular mechanisms that underlie the development of severe pneumonia, identify diagnostic tools, explore potential therapeutic targets, and test clinical interventions during pneumococcal pneumonia.

objectiveTo develop a non-human primate model of pneumococcal pneumonia.

methodsSeven adult baboons (Papio cynocephalus) were surgically tethered to a continuous monitoring system that recorded heart rate, temperature, and electrocardiography. Animals were inoculated with 109 colony-forming units of S. pneumoniae using bronchoscopy. Three baboons were rescued with intravenous ampicillin therapy. Pneumonia was diagnosed using lung ultrasonography and ex vivo confirmation by histopathology and immunodetection of pneumococcal capsule. Organ failure, using serum biomarkers and quantification of bacteremia, was assessed daily.

resultsChallenged animals developed signs and symptoms of pneumonia 4 days after infection. Infection was characterized by the presence of cough, tachypnea, dyspnea, tachycardia and fever. All animals developed leukocytosis and bacteremia 24 hours after infection. A severe inflammatory reaction was detected by elevation of serum cytokines, including Interleukin (IL)1Ra, IL-6, and IL-8, after infection. Lung ultrasonography precisely detected the lobes with pneumonia that were later confirmed by pathological analysis. Lung pathology positively correlated with disease severity. Antimicrobial therapy rapidly reversed symptomology and reduced serum cytokines.

conclusionsWe have developed a novel animal model for severe pneumococcal pneumonia that mimics the clinical presentation, inflammatory response, and infection kinetics seen in humans. This is a novel model to test vaccines and treatments, measure biomarkers to diagnose pneumonia, and predict outcomes.

Indexed as

Streptococcus pneumoniaeAnimalsBiomarkersBiopsyCytokinesDisease Models, AnimalHemodynamicsInflammation MediatorsLungPapioPhenotypePneumonia, PneumococcalPrimatesSeverity of Illness IndexUltrasonographyBiomarkersCytokinesInflammation Mediators

Identifiers

PMID27855182
PMCPMC5113940
OpenAlexW2549874827

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.